The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Richard S. Finn

Department of Medicine

Division of Hematology

Oncology

Geffen School of Medicine

USA

[email]@*.ucla.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, Division of Hematology, Oncology, Geffen School of Medicine, USA. 2007 - 2012
  • Hematology/Oncology, Geffen School of Medicine at University of California Los Angeles Los Angeles, CA 90095, USA. 2003 - 2010

References

  1. Dacomitinib (PF-00299804), an Irreversible Pan-HER Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib. Kalous, O., Conklin, D., Desai, A.J., O'Brien, N.A., Ginther, C., Anderson, L., Cohen, D.J., Britten, C.D., Taylor, I., Christensen, J.G., Slamon, D.J., Finn, R.S. Mol. Cancer Ther. (2012) [Pubmed]
  2. Advanced HCC: emerging molecular therapies. Finn, R.S. Minerva. Gastroenterol. Dietol (2012) [Pubmed]
  3. Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study. Finn, R.S., Bengala, C., Ibrahim, N., Roché, H., Sparano, J., Strauss, L.C., Fairchild, J., Sy, O., Goldstein, L.J. Clin. Cancer Res. (2011) [Pubmed]
  4. Drug therapy: sorafenib. Finn, R.S. Hepatology (2010) [Pubmed]
  5. Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now? Finn, R.S. Clin. Cancer Res. (2010) [Pubmed]
  6. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Finn, R.S., Dering, J., Conklin, D., Kalous, O., Cohen, D.J., Desai, A.J., Ginther, C., Atefi, M., Chen, I., Fowst, C., Los, G., Slamon, D.J. Breast Cancer Res. (2009) [Pubmed]
  7. Estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paclitaxel with lapatinib or placebo as first-line treatment in HER2-negative or unknown metastatic breast cancer. Finn, R.S., Press, M.F., Dering, J., Arbushites, M., Koehler, M., Oliva, C., Williams, L.S., Di Leo, A. J. Clin. Oncol. (2009) [Pubmed]
  8. Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study. Finn, R.S., Gagnon, R., Di Leo, A., Press, M.F., Arbushites, M., Koehler, M. J. Clin. Oncol. (2009) [Pubmed]
  9. Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model. Finn, R.S., Bentley, G., Britten, C.D., Amado, R., Busuttil, R.W. Liver Int. (2009) [Pubmed]
  10. Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab. Finn, R.S., Zhu, A.X. Expert. Rev. Anticancer. Ther (2009) [Pubmed]
  11. Targeting Src in breast cancer. Finn, R.S. Ann. Oncol. (2008) [Pubmed]
  12. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro. Finn, R.S., Dering, J., Ginther, C., Wilson, C.A., Glaspy, P., Tchekmedyian, N., Slamon, D.J. Breast Cancer Res. Treat. (2007) [Pubmed]
  13. Monoclonal antibody therapy for breast cancer: herceptin. Finn, R.S., Slamon, D.J. Cancer. Chemother. Biol. Response. Modif (2003) [Pubmed]
 
WikiGenes - Universities